1. Home
  2. IQMX vs VSTM Comparison

IQMX vs VSTM Comparison

Compare IQMX & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQM Quantum Computers Oyj American Depositary Shares

IQMX

IQM Quantum Computers Oyj American Depositary Shares

SELL

Current Price

$6.56

Market Cap

1.3B

Sector

N/A

ML Signal

SELL

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$6.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQMX
VSTM
Founded
2018
2010
Country
Finland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2026
2011

Fundamental Metrics

Financial Performance
Metric
IQMX
VSTM
Price
$6.56
$6.60
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$14.33
★ $17.22
AVG Volume (30 Days)
149.7K
★ 3.0M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 17.49
EPS
★ N/A
N/A
Revenue
N/A
★ $30,914,000.00
Revenue This Year
$41.60
$248.46
Revenue Next Year
$63.55
$34.25
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 209.14
52 Week Low
$6.26
$3.43
52 Week High
$15.10
$10.82

Technical Indicators

Market Signals
Indicator
IQMX
VSTM
Relative Strength Index (RSI) 37.35 30.83
Support Level N/A $5.26
Resistance Level $11.04 $8.59
Average True Range (ATR) 0.49 0.59
MACD -0.08 -0.33
Stochastic Oscillator 32.09 2.11

Price Performance

Historical Comparison
IQMX
VSTM

About IQMX IQM Quantum Computers Oyj American Depositary Shares

IQM Quantum Computers Oyj is engaged in superconducting quantum computing and provides quantum computing systems and cloud platform access to enterprises, research institutions, high-performance computing centers, and national laboratories. Its offerings include quantum systems based on an open and modular architecture. The company has operations in Munich, Germany, and deployments across Europe, Asia, and North America.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: